Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDU.S. Physical Therapy, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $0.56 | $0.56 | $0.56 |
| Q2 2024 | 3 | $0.82 | $0.82 | $0.82 |
| Q3 2024 | 2 | $0.61 | $0.73 | $0.68 |
| Q4 2024 | 6 | $0.55 | $0.76 | $0.69 |
| Q1 2025 | 3 | $0.36 | $0.60 | $0.49 |
| Q2 2025 | 2 | $0.68 | $0.82 | $0.77 |
| Q3 2025 | 2 | $0.63 | $0.76 | $0.71 |
| Q4 2025 | 2 | $0.69 | $0.83 | $0.78 |
U.S. Physical Therapy, Inc. Earnings Date And Information
U.S. Physical Therapy, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.69 earnings per share for the quarter, topping analysts' consensus estimates of $0.68 by $0.0099999999999999. The company had revenue of 168.03 M for the quarter and had revenue of 604.80 M for the year. U.S. Physical Therapy, Inc. has generated $1 earnings per share over the last year ($1.28 diluted earnings per share) and currently has a price-to-earnings ratio of 102.38. U.S. Physical Therapy, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
U.S. Physical Therapy, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | $0.39 | $164.32 M | $168.03 M | ||
| 08/14/2024 | Q2 2024 | $0.47 | $163.34 M | $167.19 M | ||
| 05/08/2024 | Q1 2024 | $0.46 | $155.68 M | |||
| 02/29/2024 | Q4 2023 | -$0.38 | $154.80 M | |||
| 11/08/2023 | Q3 2023 | $0.51 | $148.85 M | $150.01 M | ||
| 08/09/2023 | Q2 2023 | $0.64 | $151.06 M | $151.49 M | ||
| 05/05/2023 | Q1 2023 | $0.88 | $148.51 M | |||
| 02/28/2023 | Q4 2022 | $0.20 | $141.18 M | |||
| 11/08/2022 | Q3 2022 | $0.72 | $138.03 M | $139.60 M | ||
| 08/08/2022 | Q2 2022 | $0.87 | $143.09 M | $140.66 M | ||
| 05/09/2022 | Q1 2022 | $0.93 | $131.70 M | |||
| 03/01/2022 | Q4 2021 | $0.73 | $129.83 M | |||
| 11/09/2021 | Q3 2021 | $0.66 | $124.67 M | $125.89 M | ||
| 08/09/2021 | Q2 2021 | $0.82 | $122.57 M | $126.93 M | ||
| 05/10/2021 | Q1 2021 | $0.07 | $112.37 M | |||
| 03/01/2021 | Q4 2020 | $1.01 | $117.47 M | |||
| 11/06/2020 | Q3 2020 | $0.85 | $103.44 M | $108.93 M | ||
| 08/07/2020 | Q2 2020 | $0.99 | $87.24 M | $83.86 M | ||
| 05/21/2020 | Q1 2020 | $0.20 | $0.20 | 0 | $112.72 M | |
| 02/28/2020 | Q4 2019 | $0.55 | $122.11 M |
U.S. Physical Therapy, Inc. Earnings: FAQ's
When is U.S. Physical Therapy, Inc.'s earnings date?
U.S. Physical Therapy, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
Did U.S. Physical Therapy, Inc. beat their earnings estimates last
quarter?
In the previous quarter, U.S. Physical Therapy, Inc. (:USPH) reported $0.69 earnings per share (EPS) to beat the analysts' consensus estimate of $0.68 by $0.0099999999999999.
How can I listen to U.S. Physical Therapy, Inc.'s earnings conference
call?
The conference call for U.S. Physical Therapy, Inc.'s latest earnings report can be listened to online.
How can I read U.S. Physical Therapy, Inc.'s conference call transcript?
The conference call transcript for U.S. Physical Therapy, Inc.'s latest earnings report can be read online.
How much revenue does U.S. Physical Therapy, Inc. generate each year?
U.S. Physical Therapy, Inc. (:USPH) has a recorded annual revenue of $604.80 M.
How much profit does U.S. Physical Therapy, Inc. generate each year?
U.S. Physical Therapy, Inc. (:USPH) has a recorded net income of $604.80 M. U.S. Physical Therapy, Inc. has generated $1.28 earnings per share over the last four quarters.
What is U.S. Physical Therapy, Inc.'s price-to-earnings ratio?
U.S. Physical Therapy, Inc. (:USPH) has a price-to-earnings ratio of 102.38 and price/earnings-to-growth ratio is -9.04.